N-[5-chloro-1-(2-ethoxy-ethyl)-3-ethyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl]-4-methyl-pyridin-2-ylamine | 792971-02-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡唑并嘧啶类
• 英文名称: N-[5-chloro-1-(2-ethoxy-ethyl)-3-ethyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl]-4-methyl-pyridin-2-ylamine
• 英文别名: N-[5-chloro-1-(2-ethoxyethyl)-3-ethyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl]-4-methylpyridin-2-ylamine；5-chloro-1-(2-ethoxyethyl)-3-ethyl-N-(4-methylpyridin-2-yl)pyrazolo[4,3-d]pyrimidin-7-amine
• CAS: 792971-02-9
• 化学式: C₁₇H₂₁ClN₆O
• 分子量: 360.846
• InChiKey: MTKQLRSZKIIOTP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  25
• 可旋转键数：
  7
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.41
• 拓扑面积：
  77.8
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  4-哌啶甲酸 、 N-[5-chloro-1-(2-ethoxy-ethyl)-3-ethyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl]-4-methyl-pyridin-2-ylamine 在 potassium carbonate 作用下， 以 二甲基亚砜 为溶剂， 反应 20.0h， 生成 1-[1-(2-ethoxy-ethyl)-3-ethyl-7-(4-methyl-pyridin-2-ylamino)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-piperidine-4-carboxylic acid
  参考文献：
  名称：

  WO2007/54778

  摘要：

  公开号：
• 作为产物：
  描述：

  2-氨基-4-甲基吡啶 、 5,7-dichloro-1-(2-ethoxy-ethyl)-3-ethyl-1H-pyrazolo[4,3-d]pyrimidine 在 lithium hexamethyldisilazane 作用下， 以 四氢呋喃 为溶剂， 反应 0.5h， 生成 N-[5-chloro-1-(2-ethoxy-ethyl)-3-ethyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl]-4-methyl-pyridin-2-ylamine
  参考文献：
  名称：

  WO2007/54778

  摘要：

  公开号：

文献信息

• [EN] 5,7-DIAMINOPYRAZOLO`4,3-D!PYRIMIDINES USEFUL IN THE TREATMENT OF HYPERTENSION<br/>[FR] 5,7-DIAMINOPYRAZOLO`4,3-D!PYRIMIDINES UTILES POUR LE TRAITEMENT DE L'HYPERTENSION
  申请人：PFIZER LTD

  公开号：WO2004096810A1

  公开（公告）日：2004-11-11

  This invention relates to compounds of formula (I).

  这项发明涉及到式(I)的化合物。
• 1-(1-(2-Ethoxyethyl)-3-Ethyl-7-(4-Methylpyridin-2-Ylamino)-1H-Pyrazolo[4,3-D]Pyrimidin-5-YL) Piperidine-4-Carboxylic Acid And Salts Thereof
  申请人：Tollefson Michael B.

  公开号：US20110059993A1

  公开（公告）日：2011-03-10

  The present invention comprises 1-(1-(2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1H-pyrazolo[4,3-d]pyrimidin-5-yl)piperidine-4-carboxylic acid and its salts. The invention further comprises pharmaceutical compositions, methods of treatment, and synthetic methods relating to 1-(1-(2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1H-pyrazolo[4,3-d]pyrimidin-5-yl)piperidine-4-carboxylic acid and its salts.

  本发明涉及1-(1-(2-乙氧基乙基)-3-乙基-7-(4-甲基吡啶-2-基氨基)-1H-吡唑并[4,3-d]嘧啶-5-基)哌啶-4-羧酸及其盐。该发明还涉及与1-(1-(2-乙氧基乙基)-3-乙基-7-(4-甲基吡啶-2-基氨基)-1H-吡唑并[4,3-d]嘧啶-5-基)哌啶-4-羧酸及其盐相关的药物组合物、治疗方法和合成方法。
• 1-(1-(2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1H-pyrazolo[4,3-d]pyrimidin-5-yl) piperidine-4-carboxylic acid and salts thereof
  申请人：Tollefson Michael B.

  公开号：US08518956B2

  公开（公告）日：2013-08-27

  The present invention comprises 1-(1-(2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1H-pyrazolo[4,3-d]pyrimidin-5-yl)piperidine-4-carboxylic acid and its salts. The invention further comprises pharmaceutical compositions, methods of treatment, and synthetic methods relating to 1-(1-(2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1H-pyrazolo[4,3-d]pyrimidin-5-yl)piperidine-4-carboxylic acid and its salts.

  本发明涵盖1-(1-(2-乙氧基乙基)-3-乙基-7-(4-甲基吡啶-2-基氨基)-1H-吡唑并[4,3-d]嘧啶-5-基)哌啶-4-羧酸及其盐。本发明还涵盖与1-(1-(2-乙氧基乙基)-3-乙基-7-(4-甲基吡啶-2-基氨基)-1H-吡唑并[4,3-d]嘧啶-5-基)哌啶-4-羧酸及其盐相关的药物组合物、治疗方法和合成方法。
• 1-(1- (2-Ethoxyethyl)-3-Ethyl-7-(4-Methylpyridin-2-Ylamino) - 1H-Pyrazolo [4,3-D] Pyrimidin-5-YL) Piperidine-4-Carboxylic acid and salts thereof
  申请人：Tollefson Michael B.

  公开号：US20090156618A1

  公开（公告）日：2009-06-18

  The present invention comprises 1-(1-(2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1H-pyrazolo[4,3-d]pyrimidin-5-yl)piperidine-4-carboxylic acid and its salts. The invention further comprises pharmaceutical compositions, methods of treatment, and synthetic methods relating to 1-(1-(2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1H-pyrazolo[4,3-d]pyrimidin-5-yl)piperidine-4-carboxylic acid and its salts.

  本发明涉及1-(1-(2-乙氧乙基)-3-乙基-7-(4-甲基吡啶-2-基氨基)-1H-吡唑并[4,3-d]嘧啶-5-基)哌啶-4-羧酸及其盐。本发明还涉及与1-(1-(2-乙氧乙基)-3-乙基-7-(4-甲基吡啶-2-基氨基)-1H-吡唑并[4,3-d]嘧啶-5-基)哌啶-4-羧酸及其盐相关的药物组合物、治疗方法和合成方法。
• 1-(2-Ethoxyethyl)-1H-pyrazolo[4,3-d]pyrimidines as potent phosphodiesterase 5 (PDE5) inhibitors
  作者：Michael B. Tollefson、Brad A. Acker、E.J. Jacobsen、Robert O. Hughes、John K. Walker、David N.A. Fox、Michael J. Palmer、Sandra K. Freeman、Ying Yu、Brian R. Bond

  DOI：10.1016/j.bmcl.2010.03.111

  日期：2010.5

  1H-Pyrazolo[4,3-d] pyrimidines are a class of potent and selective second generation phosphodiesterase 5 (PDE5) inhibitors. This work explores the potency, selectivity and efficacy of 1-(2-ethoxyethyl)-1H-pyrazolo[4,5-d] pyrimidines as PDE5 inhibitors resulting in the advancement of a clinical candidate. (C) 2010 Elsevier Ltd. All rights reserved.